Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope

Arthritis and Rheumatism

Volumn 42, Issue 7, 1999, Pages 1485-1496

  Saal, Johannes G ^a   Krimmel, Michael ^b   Steidle, Michael ^b   Gerneth, Friederike ^c   Wagner, Silvia ^b   Fritz, Peter ^d   Koch, Silvia ^b   Zacher, Josef ^b   Sell, Stefan ^b   Einsele, Hermann ^b   Müller, Claudia A ^b  

^a St Franziskus Hospital   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Inst for Med Info Processing   (Germany)

^d ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR4 ANTIGEN;

ADULT; AGED; ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; VIRUS DETECTION; VIRUS INFECTION;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BURKITT LYMPHOMA; DNA, VIRAL; EPITOPES; FEMALE; GENOTYPE; HERPESVIRUS 4, HUMAN; HLA-DR ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SYNOVIAL MEMBRANE;

EID: 0033503486     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7     Document Type: Article

References (47)

1. Sewell KL, Trentham DE. Pathogenesis of rheumatoid arthritis. Lancet 1993;1:283-6.
2. Winchester R. The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994;56:389-466.
3. Jawaheer D, Thomson W, MacGregor AJ, Carthy D, Davidson J, Dyer PA, et al. "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 1994;37:681-6.
4. Hardwick LJ, Walsh S, Butcher S, Nicod A, Shatford J, Bell J, et al. Genetic mapping of susceptibility loci in the genes involved in rheumatoid arthritis. J Rheumatol 1997;24:197-8.
5. Vaughan JH. Infection and rheumatic disease: a review. Bull Rheum Dis 1990;39:1-8.
6. Depper JM, Zvaifler NJ. Epstein-Barr virus: its relationship to the pathogenesis of rheumatoid arthritis. Arthritis Rheum 1981;24: 755-61.
7. Lotz M, Roudier J. Epstein-Barr virus and rheumatoid arthritis. In: Smolen JS, Kalden JR, Maini RN, editors. Rheumatoid arthritis. Berlin: Springer Verlag; 1992. p. 257-80.
8. Lygard PM, Irving WL. Is there a role for Epstein-Barr virus in the etiology of rheumatoid arthritis? Br J Rheumatol 1988;27:120-7.
9. Alspaugh MA, Tan EM. Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen: demonstration by precipitation and immunofluorescence. Arthritis Rheum 1976;19:711-9.
10. Billings PB, Hoch SO, White PJ, Carson DA, Vaughan JH. Antibodies to the Epstein-Barr virus nuclear antigen and the rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc Natl Acad Sci U S A 1983;80:7104-8.
11. Youinou P, Buisson M, Berthelot JM, Jamin C, Le Goff P, Genoulaz O, et al. Anti-Epstein-Barr virus nuclear antigen 1, 2A and 2B antibodies in rheumatoid arthritis patients and their relatives. Autoimmunity 1992;13:225-31.
12. Kouri T, Petersen J, Rhodes G, Aho K, Palosuo T, Heliovaara M, et al. Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. J Rheumatol 1990;17:1442-9.
13. Rumpold H, Rhodes GH, Block PL, Carson DA, Vaughan JH. The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen 1 (EBNA 1). J Immunol 1987;138: 593-9.
14. Birkenfeld P, Haratz N, Klein G, Sulitzeanu D. Cross reactivity between EBNA 1 p107 peptide, collagen and keratin: implications for the pathogenesis of rheumatoid arthritis. Clin Immunol Immunopathol 1989;54:14-25.
15. Roudier J, Petersen J, Rhodes GH, Luka J, Carson DA. Susceptibility to rheumatoid arthritis maps to a T cell epitope shared by the HLA-Dw4 DR β-1 chain and the Epstein-Barr virus glycoprotein gp 110. Proc Natl Acad Sci U S A 1989;86:5104-8.
16. Salvat S, Auger I, Rochelle L, Begovich A, Geburher L, Sette A, et al. Tolerance to a self-peptide from the third hypervariable region of HLA-DRB1*0401 in rheumatoid arthritis patients and normal subjects. J Immunol 1994;153:5321-9.
17. La Cava A, Nelson JL, Ollier WER, MacGregor A, Keystone EC, Thorne JC, et al. Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis. J Clin Invest 1997;100:658-63.
18. Albani S, Keystone EC, Nelson JL, Ollier WER, La Cava A, Montemyor AC, et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial DnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med 1995;1:448-52.
19. Auger I, Escola JM, Gorvel JP, Roudier J. HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kd heat shock proteins. Nat Med 1996;2:306-10.
20. Van Eden W. Heat shock proteins as immunogenic bacterial antigens with the potential to induce and regulate autoimmune arthritis. Immunol Rev 1991;121:5-28.
21. Tosato G, Steinberg AD, Yarchoan R, Heliman CA, Pike SE, De Seau V, et al. Abnormally elevated frequency of Epstein-Barr virus infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 1984;73:1789-95.
22. Tosato G, Steinberg AD, Blaese RM. Defective EBV specific suppressor T cell function and rheumatoid arthritis. N Engl J Med 1981;305:1238-43.
23. Bardwick PA, Bluestein HG, Zvaifler NJ, Depper JM, Seegmiller JE. Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells. Arthritis Rheum 1980;23:626-32.
24. Hasler F, Bluestein HG, Zvaifler NJ, Epstein LB. Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation. J Exp Med 1983;157:173-88.
25. Koide J, Takada K, Sugiura M, Sekine H, Ito T, Saito K, et al. Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient. J Virol 1997;71:2478-81.
26. Scotet E, David-Ameline J, Peyrat MA, Moreau-Aubry A, Pinczon D, Lim A, et al. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 1996;184:1791-800.
27. Zhang L, Nikkari S, Skurnik M, Ziegler T, Luukkainen R, Möttönen T, et al. Detection of herpesviruses by polymerase chain reaction in lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum 1993;36:1080-6.
28. Newkirk MM, Watanabe Duffy KN, Leclerc J, Lambert N, Shiroky JB. Detection of cytomegalovirus, Epstein-Barr virus and herpes virus-6 in patients with rheumatoid arthritis with or without Sjögren's syndrome. Br J Rheumatol 1994;33:317-22.
29. Saal JG, Steidle M, Einsele H, Wagner S, Müller CA. Infection of the synovial membrane with Epstein Barr virus as a risk factor for rheumatoid arthritis [abstract]. Arthritis Rheum 1994;37 Suppl 9:S211.
30. Takei MK, Mitamura K, Fujiwara S, Horie T, Ryu J, Osaka S, et al. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol 1997;9:739-43.
31. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
32. Altman RD. Development of clinical criteria for classification of clinical osteoarthritis. J Rheumatol 1991;24:766-7.
33. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem 1987;162:156-9.
34. Fennewald S, van Santen V, Kieff E. Nucleotide sequence of a mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol 1984;51: 411-9.
35. Dambaugh T, Hennessey K, Chamnankit L, Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci U S A 1984;81:7632-6.
36. Rose MD, Gottlieb E, Lerner MR, Steitz JA. Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1981;1:785-96.
37. Bear R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984;310:207-11.
38. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA-DNA-typing technique. In: Tsuji K, Aizawa M, Saszuki T, editors. HLA 1991: proceedings of the 11th International Histocompatibility Workshop and Conference. Oxford: Oxford University Press;1992. p. 397-419.
39. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
40. David-Ameline J, Lim A, Davodeau F, Peyrat MA, Berthelot JM, Semana G, et al. Selection of T cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis. J Immunol 1996;157:4697-706.
41. Saal JG, Steidle M, Einsele H, Müller CA, Fritz P, Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 1992;12:147-51.
42. Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A 1998;95:8227-32.
43. Sato K, Maruyama I, Maruyama Y, Kitajima I, Nakajima Y, Hagaki M, et al. Arthritis in patients infected with human T lymphotropic virus type I: clinical and immunopathologic features. Arthritis Rheum 1991;34:714-21.
44. Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 1998;95:14447-52.
45. Van Asseldork M, Simmons M, Visser H, de Vos WM, Simmons G. Cloning nucleotide sequence and regulatory analysis of the Lactococcus lactis DnaJ gene. J Bacteriol 1993;175: 1637-44.
46. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984;310:1225-30.
47. Prang SN, Hornef MW, Jäger M, Wagner HJ, Wolf H, Schwarzmann FM. Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 1997;89:1665-77.